Thermo Fisher Scientific (TMO) Confirms Offer to Acquire QIAGEN (QGEN) Shares Expires on August 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St futures slip as oil surge puts markets on edge
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
UPDATE: Qiagen (QGEN) Tops Q2 EPS by 9c, Revenues Beat; Boards Reaffirms Unanimous Recommendation Shareholders Accept Thermo Fisher (TMO) Offer
August 4, 2020 4:21 PM EDT(Updated - August 4, 2020 4:22 PM EDT)
Qiagen (NYSE: QGEN) reported Q2 EPS of $0.55, $0.09 better than the analyst estimate of $0.46. Revenue for the quarter came in at $443.3 million versus the consensus estimate of $425.82 million.
Q2 2020 results:Net sales of $443.3 million (+16% actual, +19% CER)Diluted EPS $0.38; adjusted EPS $0.55 ($0.56 CER, +70% CER)H1 2020 results:Net sales of $815.3 million (+12% actual, +14% CER)Diluted EPS $0.56; adjusted EPS $0.89 ($0.90 CER, +50% CER)QIAGEN Boards have reaffirmed unanimous recommendation that QIAGEN... More